Skip to main content

Mr. Dean Swanberg Announces Disposition of Securities of Zedcor Inc.

Newsfile - Mon Jun 24, 7:50PM CDT

Grande Prairie, Alberta--(Newsfile Corp. - June 24, 2024) - Mr. Dean Swanberg announces that on June 24, 2024 he disposed of ownership over 1,500,000 common shares (the "Common Shares") of Zedcor Inc. ("Zedcor") through a private transaction. Each share was sold at $1.24 for an aggregate sales price of $1,860,000. The Common Shares of Zedcor are listed on the TSX Venture Exchange under the trading symbol ZDC.

As a result of the foregoing, Mr. Swanberg now beneficially owns and has direction or control over a total of 20,000,000 Common Shares of Zedcor, representing 20.9% of Zedcor's issued and outstanding Common Shares on a non-diluted basis.

Prior to the disposition of Common Shares, Mr. Swanberg held or had control or direction over 21,500,000 Common Shares, representing approximately 22.5% of the issued and outstanding Common Shares of Zedcor on a non-diluted basis.

The securities were sold for investment purposes. Mr. Swanberg may from time to time, depending on market conditions and other factors, acquire additional securities of Zedcor, or continue to hold or dispose of some or all of the securities of Zedcor directly or indirectly held by him in the open market, by private agreement or otherwise.

For further details regarding the disposition of the Common Shares described above, see the Early Warning Report dated June 24, 2024 available on Zedcor's SEDAR+ profile.

The address of Zedcor is 300, 151 Canada Olympic Road SW, Calgary, Alberta T3B 6B7. The address of Mr. Swanberg is 720058 Range Road 51, County of Grande Prairie No. 1, Alberta T8X 4G1.

FOR FURTHER INFORMATION OR TO OBTAIN A COPY OF THE EARLY WARNING REPORT FILED IN CONNECTION WITH THIS MATTER, PLEASE CONTACT:

Dean Swanberg

Email: dean@zedcor.ca

Telephone: 780-876-2354

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/214264

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.